Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
出版年份 2022 全文链接
标题
Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence
作者
关键词
-
出版物
Frontiers in Molecular Biosciences
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-25
DOI
10.3389/fmolb.2022.836417
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidemiology of Triple-Negative Breast Cancer
- (2021) Frederick M. Howard et al. CANCER JOURNAL
- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
- (2021) H. Kuroda et al. Clinical & Translational Oncology
- Recent Progress on NIR-II Photothermal Therapy
- (2021) Yunguang Zhang et al. Frontiers in Chemistry
- Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review
- (2021) Sergiusz Łukasiewicz et al. Cancers
- Is There One Key Step in the Metastatic Cascade?
- (2021) Antoine M. Dujon et al. Cancers
- Mutational Landscape of Pirin and Elucidation of the Impact of Most Detrimental Missense Variants That Accelerate the Breast Cancer Pathways: A Computational Modelling Study
- (2021) Muhammad Suleman et al. Frontiers in Molecular Biosciences
- Discovery of Novel Inhibitors From Medicinal Plants for V-Domain Ig Suppressor of T-Cell Activation
- (2021) Iqra Muneer et al. Frontiers in Molecular Biosciences
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques
- (2020) Quanbin Zhang et al. Scientific Reports
- Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
- (2020) Rita Nanda et al. JAMA Oncology
- The effect of vitamin D supplementation on the risk of breast cancer: a trial sequential meta-analysis
- (2020) Liguang Zhou et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
- (2020) Mauricio A. Medina et al. International Journal of Environmental Research and Public Health
- Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women
- (2020) Eun Young Kim et al. CANCER
- Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care
- (2020) Sima Singh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
- (2020) Ryan Kolb et al. Cancers
- Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
- (2019) Wei-Siang Liao et al. Acta Biomaterialia
- Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection
- (2019) Xue Wang et al. Oncology Research and Treatment
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
- (2019) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations
- (2019) Ji-Wei Chang et al. CARCINOGENESIS
- Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
- (2019) Wijden Mahfoudh et al. Journal of Translational Medicine
- Current Landscape of Immunotherapy in Breast Cancer
- (2019) Sylvia Adams et al. JAMA Oncology
- Inherited variants in XRCC2 and the risk of breast cancer
- (2019) Wojciech Kluźniak et al. BREAST CANCER RESEARCH AND TREATMENT
- Investigating the risk of breast cancer among women exposed to chemicals: a nested case–control study using improved exposure estimates
- (2019) Cecilia Videnros et al. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
- Temporal trends in breast cancer survival by race and ethnicity: A population-based cohort study
- (2019) Deirdre A. Hill et al. PLoS One
- CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
- (2019) Lei Nie et al. Nature Communications
- Occupational Chemical Exposure and Breast Cancer Risk According to Hormone Receptor Status: A Systematic Review
- (2019) Veruscka Leso et al. Cancers
- Light-Activated Core–Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
- (2018) Qingshuo Meng et al. ACS Nano
- Dietary Patterns and Breast Cancer Risk: A Systematic Review
- (2018) AKHILA DANDAMUDI et al. ANTICANCER RESEARCH
- Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases
- (2018) Ruijing Liang et al. BIOMATERIALS
- Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study
- (2018) Louise E Johns et al. BRITISH JOURNAL OF CANCER
- Family History and Risk of Second Primary Breast Cancer afterIn SituBreast Carcinoma
- (2018) Michelle L. Baglia et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Inference of Transcriptional Regulation from Expression Data Using Model Integration
- (2018) Long Wang et al. Current Bioinformatics
- Breast cancer family history and allele-specific DNA methylation in the legacy girls study
- (2018) Hui-Chen Wu et al. Epigenetics
- Prognosis and outcome in CDH1-mutant lobular breast cancer
- (2018) Giovanni Corso et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer in Men
- (2018) Sharon H. Giordano NEW ENGLAND JOURNAL OF MEDICINE
- The critical role of p16/Rb pathway in the inhibition of GH3 cell cycle induced by T-2 toxin
- (2018) Zainab Fatima et al. TOXICOLOGY
- Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
- (2018) Thibault Fiolet et al. BMJ-British Medical Journal
- Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
- (2018) Thibault Fiolet et al. BMJ-British Medical Journal
- Discovery of selective inhibitors for cyclic AMP response element-binding protein
- (2018) Iqra Muneer et al. ANTI-CANCER DRUGS
- Diet and risk of breast, endometrial and ovarian cancer: UK Women’s Cohort Study
- (2018) Yashvee Dunneram et al. BRITISH JOURNAL OF NUTRITION
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index
- (2018) Neil M. Iyengar et al. JAMA Oncology
- Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field
- (2017) Clinton Yam et al. ONCOLOGIST
- Alcohol Use and Breast Cancer: A Critical Review
- (2016) Kevin D. Shield et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
- (2016) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
- (2016) Jacqueline Tsai et al. ANNALS OF SURGICAL ONCOLOGY
- Incidence and Mortality and Epidemiology of Breast Cancer in the World
- (2016) Mahshid Ghoncheh et al. Asian Pacific Journal of Cancer Prevention
- Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer
- (2016) Na Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Microsatellite Instability as a Biomarker for PD-1 Blockade
- (2016) J. C. Dudley et al. CLINICAL CANCER RESEARCH
- Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6 ) in breast cancer
- (2016) Gabriele Corda et al. JOURNAL OF PATHOLOGY
- Radiation therapy for breast cancer: Literature review
- (2016) Karunakaran Balaji et al. Medical Dosimetry
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Notch signaling: its roles and therapeutic potential in hematological malignancies
- (2016) Yisu Gu et al. Oncotarget
- Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
- (2016) Hmwe H Kyu et al. BMJ-British Medical Journal
- Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013
- (2016) Hmwe H Kyu et al. BMJ-British Medical Journal
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
- (2016) Akio Ohta Frontiers in Immunology
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
- (2016) Sasha E. Stanton et al. JAMA Oncology
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Genetics of breast cancer: a topic in evolution
- (2015) S. Shiovitz et al. ANNALS OF ONCOLOGY
- Breast cancer risk associated with benign breast disease: systematic review and meta-analysis
- (2015) Sara W. Dyrstad et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic targets of triple-negative breast cancer: a review
- (2015) Vinayak S Jamdade et al. BRITISH JOURNAL OF PHARMACOLOGY
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Notch signaling: An emerging therapeutic target for cancer treatment
- (2015) Xun Yuan et al. CANCER LETTERS
- The effect of environmental chemicals on the tumor microenvironment
- (2015) Stephanie C. Casey et al. CARCINOGENESIS
- Obesity in breast cancer – What is the risk factor?
- (2015) F.R. James et al. EUROPEAN JOURNAL OF CANCER
- Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
- (2015) Ravi Singh et al. International Journal of Nanomedicine
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells
- (2015) Dinesh Vyas et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Near infrared light-actuated gold nanorods with cisplatin–polypeptide wrapping for targeted therapy of triple negative breast cancer
- (2015) Bing Feng et al. Nanoscale
- Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer
- (2015) Hong-Mei Zheng et al. TUMOR BIOLOGY
- Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
- (2015) Yu-Chun Hsiao et al. Oncotarget
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Effects of Age on the Detection and Management of Breast Cancer
- (2015) Andrew McGuire et al. Cancers
- Importance of a Personal History of Breast Cancer as a Risk Factor for the Development of Subsequent Breast Cancer: Results From Screening Breast MRI
- (2014) David V. Schacht et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact
- (2014) J. M. Nabholtz et al. ANNALS OF ONCOLOGY
- Juxtacrine Signaling Is Inherently Noisy
- (2014) Tomer Yaron et al. BIOPHYSICAL JOURNAL
- Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters
- (2014) Leena Hilakivi-Clarke BREAST CANCER RESEARCH
- Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study
- (2014) A Castelló et al. BRITISH JOURNAL OF CANCER
- FRET Enhanced Fluorescent Nanodiamonds
- (2014) Rafal Fudala et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
- (2014) Elvin Blanco et al. MOLECULAR THERAPY
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Minimizing second cancer risk following radiotherapy: current perspectives
- (2014) John Ng et al. Cancer Management and Research
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial
- (2013) Olöf Bjarnadottir et al. BREAST CANCER RESEARCH AND TREATMENT
- Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up
- (2013) Xuehong Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Bioactivity of Turmeric-derived Curcuminoids and Related Metabolites in Breast Cancer
- (2013) Laura Wright et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of Alcohol on the Endocrine System
- (2013) Nadia Rachdaoui et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The Effect of Curcumin on Breast Cancer Cells
- (2013) Dongwu Liu et al. Journal of Breast Cancer
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
- (2013) Miguel Martín et al. JOURNAL OF CLINICAL ONCOLOGY
- Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies
- (2013) LANCET ONCOLOGY
- Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
- (2013) Koichiro Hayashi et al. Theranostics
- The Relationship of Mammographic Density and Age: Implications for Breast Cancer Screening
- (2012) Cristina M. Checka et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
- (2012) Mike De Vos et al. BIOCHEMICAL PHARMACOLOGY
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Targeting the Hedgehog signaling pathway for cancer therapy
- (2012) Yiwei Li et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment
- (2012) Sook Ryun Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
- (2011) Leif W. Ellisen CANCER CELL
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
- (2011) Suzanne A. Eccles INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
- (2011) A. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- Hormone replacement therapy and the risk of breast cancer
- (2011) Steven A. Narod Nature Reviews Clinical Oncology
- Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol
- (2011) Robert N. Hoover et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
- (2010) Melinda Protani et al. BREAST CANCER RESEARCH AND TREATMENT
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
- (2010) Xinhui Wang et al. JNCI-Journal of the National Cancer Institute
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
- (2009) Sharon Nofech-Mozes et al. BREAST CANCER RESEARCH AND TREATMENT
- The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
- (2009) Rui Benedito et al. CELL
- The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
- (2008) Jiyoung Rhee et al. BMC CANCER
- The prognostic importance of triple negative breast carcinoma
- (2008) Hakan Mersin et al. BREAST
- Impact of Triple Negative Phenotype on Breast Cancer Prognosis
- (2008) Henry G. Kaplan et al. Breast Journal
- Prognostic Value of Triple-Negative Phenotype at the Time of Locally Recurrent, Conservatively Treated Breast Cancer
- (2008) Rahul R. Parikh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Notch3: from subtle structural differences to functional diversity
- (2008) D Bellavia et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now